Loading insider details...
Beta
Latest Form 4 (Mar 13, 2026): Exercise/Conversion of 60,000 AVIR shares, $74.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 13, 2026 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 60,000 | $74.4K |
| Feb 4, 2026 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 54,866 | n/a |
| Feb 4, 2025 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 44,367 | n/a |
| Feb 3, 2024 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 44,367 | n/a |
| Feb 2, 2023 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 133,100 | n/a |
| Feb 2, 2022 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 181,000 | n/a |
| Feb 1, 2021 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 148,850 | n/a |
| Nov 4, 2020 | Atea Pharmaceuticals, Inc. (AVIR) | Conversion | 133,004 | n/a |